Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adecatumumab +/- FOLFOX in Resected Colorectal Liver Metastases
NCT00866944Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2009
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of adecatumumab in colorectal cancer (CRC), sponsored by Amgen. Started Mar 2009; status: completed.
02
Drugs
adecatumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00866944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866944.